SCS Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.7M Sell
105,264
-46,058
-30% -$10.7M 0.25% 57
2026
Q1
$37M Sell
151,322
-10,043
-6% -$2.34M 0.39% 38
2025
Q4
$33.4M Sell
161,365
-4,300
-3% -$850K 0.35% 48
2025
Q3
$30.7M Sell
165,665
-5,999
-3% -$1.03M 0.33% 53
2025
Q2
$26.2M Buy
171,664
+115,759
+207% +$17.8M 0.29% 56
2025
Q1
$9.27M Buy
+55,905
New +$8.75M 0.12% 94

Other funds holding JNJ

SCS Capital Management's JNJ Position: Q2 2026 in Review

SCS Capital Management reduced its Johnson & Johnson (JNJ) stake by 30% in Q2 2026, selling an estimated $10.7M and leaving 105,264 shares worth $26.7M. The position accounts for 0.25% of the portfolio, ranked #57.

SCS Capital Management first reported a position in JNJ in Q1 2025 and has held it in 6 quarters since. The position peaked at $37M in Q1 2026. 4,685 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • SCS Capital Management held 105,264 shares of Johnson & Johnson worth $26.7M as of Q2 2026.
  • SCS Capital Management sold 46,058 Johnson & Johnson shares in Q2 2026, an estimated $10.7M.
  • Johnson & Johnson made up 0.25% of SCS Capital Management's portfolio in Q2 2026, its #57 holding.
  • SCS Capital Management first reported a position in Johnson & Johnson in Q1 2025 and has held it in 6 quarters since.
  • SCS Capital Management's Johnson & Johnson position peaked at $37M in Q1 2026.
  • 4,685 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on SCS Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.